ACE and diabetes mellitus: The US Renal Data System reports that only 26% of patients with CKD received medical evaluation with serum creatinine level, lipid levels, and microalbuminuria in 2007, and only 67% of individuals with diabetes and CKD received ACE inhibitors/ARBs.1